跳至主要内容
临床试验/CTRI/2023/08/057001
CTRI/2023/08/057001尚未招募不适用

Outcome of New Onset Septic Shock in ICU population

Max Super Speciality Hospital1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2023年3月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
41
试验地点
1
主要终点
Mortality in ICU patients developing new onset septic shock

研究概览

简要总结

This is a prospective observational study in which we aim to study the incidence, ICU course and outcome in terms of 28 days mortality. The primary outcome measures will be 28 days mortality in ICU patients developing new onset septic shock. The secondary  outcome will be need and duration for vasopressors, need and duration for renal replacement therapy, risk factors for 28 days mortality, source of infection, ICU and hospital length of stay.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patient admitted in Intensive care unit.
  • Developing septic shock after 48 hours of ICU admission.
  • Patients diagnosed with new onset septic shock according to sepsis 3 definition ( septic shock defined as suspected or confirmed infection plus hyperlactatemia ( more than 2 mmol per litre) and requirement of vasopressor to maintain a mean arterial pressure of 65 mmHg or higher after intravenous fluid resuscitation as per surviving sepsis guidelines.

排除标准

  • Patients below 18 years of age.
  • Patients developing shock within 48 hours of ICU admission.
  • Patients with End of life care.

结局指标

主要结局

Mortality in ICU patients developing new onset septic shock

时间窗: 28 days

次要结局

  • Need & duration of vas opressors.(28 days)
  • Need of renal replacement therapy & it’s duration(28 days)
  • ICU & hospital length of stay.(28 days)
  • Source of infection(28 days)
  • Risk factors for 28 days mortality(28 days)
  • Need of invasive mechanical ventilation & it’s duration(28 days)
  • Effect of timing of appropriate antibiotics on mortality(28 days)

研究者

申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验